Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib ; volume:7 ; number:1 ; day:24 ; month:1 ; year:2018 ; pages:1-4 ; date:12.2018
Experimental hematology & oncology ; 7, Heft 1 (24.1.2018), 1-4, 12.2018
- Keyword
-
Krebs
Onkologie
- Creator
-
Sgroi, V.
- Contributor
-
Bassanelli, M.
Roberto, M.
Iannicelli, E.
Porrini, R.
Pellegrini, P.
Tafuri, A.
Marchetti, P.
SpringerLink (Online service)
- DOI
-
10.1186/s40164-018-0094-9
- URN
-
urn:nbn:de:1111-2018032223160
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sgroi, V.
- Bassanelli, M.
- Roberto, M.
- Iannicelli, E.
- Porrini, R.
- Pellegrini, P.
- Tafuri, A.
- Marchetti, P.
- SpringerLink (Online service)
Other Objects (12)
Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma
Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia
Dasatinib—A Generation Ahead
Exacerbation of pleural effusion in a dasatinib-treated patient during the perioperative period
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
Capecitabine-Associated Terminal Ileitis
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib
Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma
Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia
Dasatinib—A Generation Ahead
Exacerbation of pleural effusion in a dasatinib-treated patient during the perioperative period
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
Capecitabine-Associated Terminal Ileitis
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with Dasatinib
Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma
Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia
Dasatinib—A Generation Ahead
Exacerbation of pleural effusion in a dasatinib-treated patient during the perioperative period
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
Capecitabine-Associated Terminal Ileitis